Top Medical Startups in 2027

Founded in 2018, we are a group of imaging scientists, engineers, and radiologists aspired to improve healthcare by creating novel medical imaging technology and bringing it to every patient that needs it. Our core technology has its roots at Stanford University, where our founders created the first-ever radiofrequency-penetrable PET insert system for simultaneous PET and MRI imaging. ​Our vision is to make multi-modality medical imaging accessible to every patient. Our mission is to create affordable, high-performance molecular imaging systems that empower doctors to drive early and accurate diagnosis of diseases.

Neuralink is developing a fully-implanted, wireless, high-channel count brain-machine interface (BMI) with the goal of enabling people with paralysis to directly use their neural activity to operate computers and mobile devices with speed and ease. Neuralink was founded in 2016 by Elon Musk and the company is headquartered in Fremont, CA with a second location opening in Austin, TX.

For the past 150 years, pathologists have been inspecting tissue visually under a light microscope to diagnose and grade cancer. This process is subjective--for many cancers, pathologists only agree with each other about 50% of the time. Over the past three years, hospitals have begun replacing microscopes with to digital, image based workflows. We tap into that digital data, and use computers to automate and quantify modern pathology workflows.

Our mission is to help dentists run a successful business. We’re transforming an old industry from a world of trusting high-cost sales reps to giving control back to business owners. Our platform already helps dentists save up to 60% off retail pricing and our users absolutely love us.

Phreesia helps medical groups and health systems leverage patient intake to achieve their strategic objectives. When we founded Phreesia in 2005, we saw an opportunity to put innovative technology into the hands of patients to automate check-in and streamline front-office workflow. Over the last decade, our platform has evolved as we incorporated eligibility and benefits verification, built our own payments platform and integrated with the leading practice management and electronic medical record systems.

Tombot makes robotic animals that transform the daily life of individuals, families and communities facing health adversities. Originally designed to meet the specific medical needs of seniors with dementia, Tombot Puppies have also been preordered for children with Autism, adults with high impact chronic pain, major depressive disorder, anxiety, bipolar disorder, and PTSD, and for long inpatient stays and arduous outpatient treatments at hospitals. Peer-reviewed studies show that robotic animals positively affect some users’ ability to cope with stress, anxiety, loneliness, depression and pain, reducing their need for psychotropic and opioid medications. Key Milestones and Metrics: • Completion of our 5th generation prototype and 3rd round of customers studies with 100s of seniors with dementia • Over 3,900 preorder and waitlist customers • Member of StartX: Stanford-funded startup accelerator program • Member of the Canadian Creative Destruction Lab accelerator program • Member of Children’s Hospital of Los Angeles accelerator program (CTIP) • Large-scale clinical trials in development with Children’s Hospital and the University of Southern California to demonstrate reduced stress, anxiety and pain for pediatric hospital inpatients • Large scale study in development with the LAC-USC Hospital Burn Unit to demonstrate reduced stress, anxiety, and pain for pediatric burn patients • Major national and international media coverage • Winner 2019 RoboBusiness Pitchfire competition • Filed multiple trademark, design and provisional utility patent applications • U.S. TAM: $9.0B (seniors with dementia plus mild cognitive impairment)

Impiricus Pulse. For doctors, it provides an opportunity to access curated clinical resources. For pharma, it is the most impactful channel to engage with their targets. Face-to-face access has diminished and Impiricus offers the only way to get in-depth connectivity. Impiricus Concierge. For doctors, its adds transparency and removes friction in accessing pharma resources. (Samples, Patient Support). For pharma is increases sales and ROI.

Axogen (AXGN) is the leading company focused specifically on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. We are passionate about helping to restore peripheral nerve function and quality of life to patients with physical damage or discontinuity to peripheral nerves by providing innovative, clinically proven and economically effective repair solutions for surgeons and health care providers. Every day, people suffer traumatic injuries or undergo surgical procedures that impact the function of their peripheral nerves. Physical damage to a peripheral nerve, or the inability to properly reconnect peripheral nerves, can result in the loss of muscle or organ function, the loss of sensory feeling, or the initiation of pain. Our comprehensive portfolio of products focuses on helping patients touch, run, feel, kiss, smile and hug—some of the many things healthy peripheral nerves allow us to do.